Pharma Business Line

Everest Medicines Enters into a Memorandum of Understanding to Partner with China Resources Pharmaceutical Group for its mRNA Vaccines Business

China Resources Pharmaceutical Group (“CR Pharma”) Intends to Make Strategic Equity Investment for Everest’s mRNA Technology Platform Partnership with CR Pharma will provide local support to navigate China regulatory pathways through mRNA vaccine platform, first in advancing Everest’s potentially best-in-class COVID-19 vaccine candidate SHANGHAI, April 6, 2022 /PRNewswire/ — Everest …

Read More »

How startups are taking the lead in health tech development – ​​PharmaLive

By Adrien Chatillon – CEO and Founder of Actipulse Neurosciences There is no doubt that COVID-19 has irreversibly changed the healthcare industry, disrupting its earlier steady development. Health and safety protocols have evolved rapidly, adapting to new challenges and market demands. To cope with pandemic-related shortages, companies needed agile and …

Read More »

Eugene Melnyk: Billionaire, tireless worker and a taste for Hawaiian shirts and fun

Breadcrumb Links News Melnyk died on Monday, aged 62, from an undisclosed illness, and those who knew him find it hard to believe he is gone Eugene Melnyk in 2018. Photo by Tony Caldwell/Postmedia Files Content of the article Eugene Melnyk wanted to be a doctor. But his path took …

Read More »

Athira Pharma Highlights Strong Strategy Execution and Positioning for the Future

Athira Pharma, Inc. BOTHELL, Wash., March 30, 2022 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ:ATHA), a late-stage clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today issued the following statement in response to Richard Kayne’s statement: Athira’s Board of Directors and management team …

Read More »

Arbitration on the cards between Gennova and HDT on the mRNA vaccine

Even as Pune-based Gennova Biopharmaceuticals awaits a regulatory green light for the country’s first Covid mRNA vaccine, its parent company, Emcure Pharmaceuticals, is facing a trade secret lawsuit from US firm HDT Bio Corp. HDT claim In a lawsuit in strong terms in federal court in Washington, HDT alleged, “Emcure …

Read More »

EMA approves two new drugs – J&J’s BCMA CAR-T for multiple myeloma, AstraZeneca’s Evusheld – plus 5 label extensions

The European Medicines Agency’s CHMP on Friday advised two new drugs for approval, AstraZeneca’s Evusheld to help prevent Covid-19, and Johnson & Johnson’s new BCMA CAR-T fourth-line treatment for multiple myeloma. Approved in the United States about four weeks ago, J&J and Legend’s new drug, sold as Carvykti, will rival …

Read More »

BofA Reinstates Cover on Gland Pharma, Glenmark Lifesciences with ‘Buy’; “Neutral” on Divi

BofA Securities reinstated coverage of active Indian pharmaceutical companies and contract drugmakers, citing lower price risk and growing opportunities. It has a “buy” rating on Gland Pharma Ltd. and Glenmark Lifesciences Ltd. and a “neutral” call on Divi’s Laboratories Ltd., the brokerage said in its March 23 report. Although most …

Read More »

Sensex up more than 696 pts at close, Nifty breaks above 17,300 amid volatility

Benchmarks rebounded strongly from early losses to close more than 1% higher on Tuesday. The market opened on a subdued note amid weak global signals and fell further during the morning session amid concerns over rising crude oil prices. The indices closed higher, indicating buying activity on several counters. The …

Read More »

Forbes India – We love buying brands, especially in the OTC space: Nandini Piramal

Nandini Piramal, Executive Director, Piramal Enterprises Ltd OOver the past few years, Piramal Group has focused on creating consumer attraction for its brands and aims to generate revenue of Rs 1,000 crore in three years from its branded product division. consumption. In an exclusive chat with Storyboard18, Nandini Piramal, …

Read More »

Borosil Seeks to Accelerate Science Division Product Exports

Kolkata, March 13 Borosil Ltd is seeking to increase exports of products including laboratory glassware and pharmaceutical primary packaging items under its scientific products division, primarily to the US and European markets. According to the COO of the SIP division, Vinayak M Patankar, exports currently account for almost 12-13% of …

Read More »

India’s February fuel demand rises, but surge in crude could slow rise

India’s fuel consumption rose 5.4% in February from the same month last year, the biggest year-on-year jump since August 2021, but soaring oil prices could slow the recovery third largest oil importer and consumer in the world. Fuel consumption, an indicator of oil demand, totaled 17.57 million tonnes for the …

Read More »

Evonik increases its plant-based cholesterol treatment capacity

Evonik increased its supply of plant-derived cholesterol, one of the most critical components for making mRNA vaccines and uncomfortable therapies. Large-scale production of PhytoChol in Hanau, Germany will meet growing market demand for cholesterol. This lipid is one of the key excipients of lipid nanoparticles (LNPs) used in COVID-19 vaccines. …

Read More »

AstraZeneca boss has bonus frozen after investor row

AstraZeneca moves to appease shareholders over chief executive’s £14million pay by promising to freeze its bonus package for three years AstraZeneca under Pascal Soriot, played a key role in the global Covid vaccination effort Pharmaceutical giant suffered shareholder rebellion last year over boss’ rewards Angry investors dramatically increased potential bonus …

Read More »

Pharma prices, margin pressure likely to ease soon: industry captains

The pharmaceutical industry is optimistic that price and margin pressure in the US market will ease in the future. According to Ajay Piramal, President of the Piramal Group, although there has been pressure on margins, especially with the uncertainty regarding costs, some of the pressure on prices has been recovered …

Read More »

BridgeBio Pharma Inc (NASDAQ:BBIO) shareholders lost 88% as shares fell 12% last week

The art and science of stock market investing requires tolerance for losing money on some of the stocks you buy. But serious investors should think long and hard to avoid extreme losses. We wouldn’t blame Bridge Bio Pharma, Inc. (NASDAQ:BBIO) shareholders were still reeling after the stock plummeted like a …

Read More »

Why invest in Nippon India Pharma Fund

With inflation taking center stage in economic discussions between central banks and investors, now may be the time to increase allocations in defensive sectors such as pharmaceuticals. A passive way to actively play the sector is an allocation to sector funds investing in the pharmaceutical industry. As the sector tackles …

Read More »

Flexible and Scalable Assembly Solutions: How Automation Meets Manufacturing’s Most Pressing Challenges

Semi-automatic assembly line for medical devices. With stricter regulatory standards, shorter product life cycles and more competition than ever before, the medical device industry is changing at an unprecedented rate. New technologies, new markets and new patient requirements are emerging, as well as a growing demand for self-diagnosis and treatment …

Read More »

LaDuke: Pharma companies that brought the COVID vaccine also caused the opioid crisis – InForum

I have a love-hate relationship with the healthcare industry. I am grateful for my medical care, but truly appalled at the exponential growth in the industry. It looks like pretty much every old box building is being turned into a clinic, for diabetes, COVID or whatever. It is not an …

Read More »

Saudi pharma major Al-Dawaa sets IPO price range, begins building books

As SNB celebrates the fastest and most significant merger, some customers have struggled to find their way JEDDAH, DUBAI: It took only 15 months for National Commercial Bank and Samba Financial Group to complete the fastest and largest merger in Middle Eastern banking history. The new entity, Saudi National Bank, …

Read More »

Carlyle Group invests in Orsini Specialty Pharma

The Carlyle Group has agreed to acquire a stake in Orsini Specialty Pharmacy, joining Consonance Capital as a roughly equal investor in the rare disease specialty pharmacy sector, sources tell Axios. Why is this important: Fueled by advances in genomics and technology, the development of drugs and gene therapies for …

Read More »

Stocks that will see action today (February 10)

Tata Steel said on Wednesday that his branch had accepted a Letter of Attribution (LoA) for the acquisition of a 93.71% stake in Neelachal Ispat Nigam Ltd (NINL) and added that the buyout process is expected to be completed within next two years. month. On February 2, the Department of …

Read More »

Emerging Trends Of The Global Triprolidine Market 2029 | Glaxosmithkline, Delta Pharma, Pai – The Grundy Register

New research on the world triprolidine market 2022-2029 incorporates potential trends, business assessment, brief segmentation outlook, competitive scenarios, and forecast estimates for the coming years. It also offers advanced statistics as well as trade information associated with the precise industry. The research report emphasizes on the essential driving and restraining …

Read More »

Behind the scenes of the rebranding of pharmaceutical giant Sanofi | Marketing

As part of these changes, Sanofi’s sub-brands, which include Sanofi Pasteur and Sanofi Genzyme, will be united under the Sanofi brand. Internally, staff members will continue to work in one of four global business units: Pasteur is the vaccines business unit and Genzyme is the specialty care business unit. The …

Read More »

Tackling the recruitment crisis in clinical trials

Why are so many clinical trials missing their recruitment deadlines, and what can be done to overcome this problem? Using clinical trials to validate new treatments is one of the most essential, yet expensive, processes in the global healthcare industry. These trials are not only expensive to conduct, but also …

Read More »

Creso Pharma (ASX:CPH) stock price jumped 6% today. here’s why

Image source: Getty Images Key points Creso Pharma share price exploded this morning before ending the day up 6% It acquired a US-based company making both CBD and non-CBD products Creso Pharma share price fell 57% in 12 months the Creso Pharma Ltd. (ASX:CPH) The stock price soared today after …

Read More »

Panacea Biotec Pharma to sell its domestic formulations business to Mankind Pharma

Panacea Biotec Pharma Limited, a subsidiary of Panacea Biotec Limited, has signed an agreement with Mankind Pharma to sell its domestic formulations business for a transaction value of ₹1,908 crore. Panacea Biotec holds the manufacturing license for the Russian Covid-19 vaccine Sputnik V. Pursuant to a regulatory filing on Tuesday, …

Read More »

Some of the Biggest Cannabis Companies Will Soon Release Their Fourth Quarter Financials – New Cannabis Ventures

the Cannabis Public Company Revenue and Revenue Tracking, managed by New Cannabis Ventures, ranks the top revenue-generating cannabis companies. This data and fact-based tracker will be continuously updated with new financial documents so readers can stay up to date. Companies must file with the SEC or SEDAR and be current …

Read More »

Health – a vital investment

Dr Audrey Derveloy, Managing Director of Novartis Pharmaceuticals Ireland and National President. What are your daily responsibilities? As Managing Director, I am responsible for the day-to-day operations of the pharmaceutical division. We have a broad portfolio spanning different therapeutic areas including Cardiology, Neurology, Oncology, Dermatology and Rheumatology. My role as …

Read More »

What competition? Vertex touts Trikafta’s competitive edge after strong 2021

Vertex ended 2021 strong, crushing analysts’ sales expectations for the full year. CEO Reshma Kewalramani, MD says the company’s well-established position in the cystic fibrosis space, where Vertex expects to maintain its lead for years to come, is worth it. Vertex captured $7.57 billion in product revenue for 2021, reporting …

Read More »

Florida is so crazy about mAbs that Ron DeSantis wants to use mAbs that don’t work – Endpoints News

Florida Governor Ron DeSantis is working so hard to politicize the FDA and demonize the federal government that he stepped into an alternate universe on Monday night by describing a recent FDA action to restrict the use of two monoclonal antibodies, or mAb, treatments for Covid-19 that do not work …

Read More »

Fewer launches slow pharmaceutical market sequential growth in December

Lower volumes along with less number of new launches slowed the growth of the Indian Pharmaceutical Market (IPM) in December 2021 on a sequential basis. According to India Ratings and Research (Ind-Ra), IPM continued to register slower growth of 5.3% YoY in December 2021 after growing 6.6% in November 2021. …

Read More »

LaBelforte launches business entities for Covid-19 nasal products

Covidrops and Covinhaler will facilitate the development of nasal and inhaled drugs that optimize the immune system. Credit: Various Stock Photos / Flickr. The Indian start-up LaBelforte has spear its special purpose business entities, Covidrops and Covinhaler, to facilitate the development of immune-optimized nasal and inhaled pharmaceuticals to treat Covid-19. …

Read More »

COVIDROPS™ and COVINHALER® – Indian Startups Seeking Nasal Sprays and Pocket Inhalers for COVID-19 Therapeutics

PUNE, India, January 19, 2022 /PRNewswire/ — As the therapeutic research landscape for COVID-19 continues to evolve, new formats of vaccines and therapies are being developed around the world to support an effective response against the virus. LaBelforte LLP, an Indian startup promoted by a Pune, announced on Wednesday the …

Read More »

Business News | Stock and Equity Market News | Financial news

Search mutual fund quotes, news, net asset values Mother-son Sumi INE775A01035, MOTHERSUMI, 517334 TataTeleservice INE517B01013, TTML, 532371 One 97 PayTM INE982J01020, PAYTM, 543396 Wipro INE075A01022, WIPRO, 507685 Vodafone Idea INE669E01016, IDEA, 532822 Search mutual fund quotes, news, net asset values Mother-son Sumi INE775A01035, MOTHERSUMI, 517334 TataTeleservice INE517B01013, TTML, 532371 One …

Read More »

When can we expect a profit from Diurnal Group plc (LON: DNL)?

Daytime Group plc (LON: DNL) Perhaps a major achievement in his business is approaching, so we would like to shed some light on the business. Diurnel Group plc operates as a specialty pharmaceutical company worldwide. On June 30, 2021, the £ 107million market-capitalization company recorded a loss of £ 10million …

Read More »

Strengthening of the Covid pharmacy

[ad_1] A new year should be the time for a new start. But with the Omicron variant of SARS-CoV-2 leading to a worldwide increase in cases, 2022 begins for the pharmaceutical industry with much the same, as it implements the skills gained over the past two years and “planned. in …

Read More »

Rupifi Raises $ 25 Million in Serie A Funding Round

[ad_1] Fintech start-up Rupifi has raised a funding round of $ 25 million from Bessemer Venture Partners and Tiger Global. Existing investors Quona Capital and Ankur Capital also participated in this round, as well as Better Capital. Founded in 2020 by Anubhav Jain, Ankit Singh and Jawaid Iqbal, this is …

Read More »

Omicron gives new impetus to the hybrid work model

[ad_1] The second wave of Covid had forced India Inc to switch to the work from home (WfH) model. And just as the return to the office was gaining momentum, the Omicron variant struck, prompting companies to reduce or stop business travel / team meetings altogether and return to the …

Read More »

Curaleaf Holdings, Inc. (CSE: CURA) on the verge of turning from loss to profit

[ad_1] With the company potentially at an important milestone, we thought we would take a closer look Curaleaf Holdings, Inc. (CSE: CURA) future perspectives. Curaleaf Holdings, Inc. operates as an integrated operator of medical and wellness cannabis in the United States. With the latest loss of US $ 62 million …

Read More »

IPOs generated exceptional returns of 57% in 2021

[ad_1] The year 2021 has turned out to be the best year for the Indian primary market. As many as 64 motherboard companies have raised around 1.2 lakh crore through Initial Public Offerings (IPOs), the highest amount raised through public issues in a single calendar year. Many of these IPOs …

Read More »

Ready to increase the production of Molnupiravir: Optimus pharma

[ad_1] Optimus Pharma has priced its Molnupiravir capsules at ₹ 630 for a vial of 10. Speaking after officially launching the product here on Thursday, Dr Srinivasa Reddy, president and CEO of Optimus Pharma, said his company was “ready” to ramp up the manufacture of Molnupiravir. Optimus now has a …

Read More »

These are 5 of my best passive income ideas

[ad_1] Some of my favorite passive income ideas are UK dividend stocks. I love the hefty dividends and the fact that I don’t have to work for income. Here are five that I would consider buying now for my wallet in an attempt to increase my passive income stream. Direct …

Read More »

WhizAI Secures $ 8 Million Series A Funding

[ad_1] WhizAI recently announced that it has raised $ 8 million in Series A funding. Those are the details. WhizAI, the first and only augmented consumer platform specifically designed for the life sciences industry, recently announced that it has raised $ 8 million in Series A funding. Vertical Venture Partners …

Read More »

We co-innovate with global pharmaceutical companies: Syngene MD & CEO

[ad_1] Syngene International, one of the first players in the CRAMS (Custom Research And Manufacturing Services) segment, was spun off from the Indian biotechnology company Biocon to offer contracted R&D capabilities and is now a fully integrated player. When global pharmaceutical majors like Glaxo Smith Kline, Bristol Myers Squibb, Amgen …

Read More »

Luye Pharma Reports First Results from Phase II Clinical Trial of New Ansofaxin Hydrochloride Extended-Release Antidepressant Tablets

[ad_1] CHONGQING, China, 23 December 2021 / PRNewswire / – Luye Pharma Group today released encouraging first results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005), at 19e Chinese Medical Association National Psychiatry Conference. In general, LY03005 demonstrated overall antidepressant efficacy as well …

Read More »

Predictive Oncology – Year-end Shareholder Update!

[ad_1] EAGAN, Minnesota, December 21, 2021 (GLOBE NEWSWIRE) – Predictive Oncology, (POAI), a knowledge-driven company focused on the application of artificial intelligence (AI) to develop personalized cancer therapies, is moving in the right direction. In November 2021, POAI acquired zPREDICTA, a leading cancer company with a proven business and scientific …

Read More »

Vincerx Pharma Announces Administration of First Patient in Phase 1 Ascending Dose Study of VIP152 for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

[ad_1] PALO ALTO, Calif., December 17, 2021 (GLOBE NEWSWIRE) – Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to meet the unmet medical needs of cancer patients through paradigm shift therapies, announced today that the first patient received a dose in the Company’s Phase 1 dose escalation study of …

Read More »

Senate Health Committee once again offers support to FDA Commissioner-designate Rob Califf – Endpoints News

[ad_1] Rob Califf, the famous cardiologist from Duke University, is expected to return to the top of the FDA, this time under the Biden administration. At her confirmation hearing on Tuesday, Democrats and Republicans on the Senate Health Committee offered their support to Califf, with President Patty Murray (D-WA) stressing …

Read More »

Sensex jumps over 350 points at the start of the trade; Clever tops 17,600

[ad_1] The benchmark Sensex stock index jumped more than 350 points at the start of Monday, following the gains of the major ICICI Bank, HDFC twins and Axis Bank indices amid a positive trend in global markets. The index of 30 stocks jumped 375.30 points or 0.64% to 59,161.97 when …

Read More »

The fierce battle for pharmaceutical self-sufficiency – the Island

[ad_1] By Hiran H. Senewiratne Kids & Teens Medical Group, one of the largest and largest pediatric primary care centers in Los Angeles, Calif., With eleven sites and operating successfully for over 15 years, will strengthen its process outsourcing operations commercial or BPO in Sri Lanka. The Kids & Teens …

Read More »

Viatris and Biocon plan to bundle their biosimilars into $ 10 billion stand-alone business – report – Endpoints News

[ad_1] According to sources from Nisha Poddar of an Indian subsidiary of CNBC, Viatris (Mylan / Pfizer’s Upjohn) and India’s Biocon Biologics are debating whether they should further combine their biosimilars business into a stand-alone $ 10 billion business. Earlier this summer, the two companies won the coveted first interchangeability …

Read More »

Antares Pharma (NASDAQ: ATRS) Shareholders Gained 10% CAGR in Past Five Years

[ad_1] While Antares Pharma, Inc. (NASDAQ: ATRS) Shareholders are probably generally happy, the stock hasn’t gone particularly well recently, with the stock price falling 13% in the last quarter. On the positive side, the stock price has risen over the past five years. Meanwhile, it’s up 64%, which isn’t bad, …

Read More »

Even as boom subsides, new $ 200 million SPAC still hopes for another big score – Endpoints News

[ad_1] The biotech industry has been booming throughout the Covid-19 pandemic – and although it has slowed down considerably, there are still more PSPCs at work. Blank check firm BioPlus Acquisition Corp announced last Thursday that it was pricing its IPO increased by 20 million units at $ 10.00 per …

Read More »

Gland Pharma (NSE: GLAND) YoY Earnings Growth Below Decent Shareholder Returns

[ad_1] Passive investing in index funds can generate returns that roughly match the overall market. But you can do better than that by choosing better-than-average stocks (as part of a diversified portfolio). For example, the Gland Pharma Limited The share price (NSE: GLAND) has risen 68% over the past year, …

Read More »

Can Johnson & Johnson put the shade of scandal behind this?

[ad_1] December 4, 2021 THENGO BEFORE the invention of stakeholder capitalism, a fundamental tenet — that the interests of customers, employees and society should be as high as or greater than those of shareholders — was set in stone at Johnson & Johnson’s corporate headquarters in New Brunswick, New Jersey. …

Read More »

Manchester U. to expand specialty pharmaceutical programs

[ad_1] (photo courtesy University of Manchester) The University of Manchester has partnered with San Diego-based Agena Bioscience to help the school expand its educational resources in the area of ​​pharmacogenomics. Pharmacogenomics is the study of how a person’s unique genetic makeup influences their response to drugs. Agena is a global …

Read More »

ERYTECH obtains a US patent for the sequential use of

[ad_1] ERYTECH obtains a US patent for Sequential use of Methioninase & Asparaginase against solid tumors Previous methioninase therapy sensitizes some types of solid tumors to asparaginase therapy New patent grant added to the portfolio of 310 patents granted in 16 patent families Cambridge, MA (US) and Lyon (France), November …

Read More »

Black Friday: New concerns over Covid variant, global indices drag Sensex down over 1,600 pts, Nifty below 17,100

[ad_1] It was chaos on Dalal Street with benchmarks closing nearly 3% lower on Friday, hitting a seven-month low as concerns over a new vaccine-resistant variant of Covid scared investors. The rupee also fell 37 paise to its lowest level in three weeks and bond yields fell as concerns mounted …

Read More »

55 pharmaceutical companies are eligible for the 15,000 crore PLI program

[ad_1] No less than 55 companies have qualified for the Production Incentive Program (PLI) for the pharmaceutical sector. The list includes such important players as Sun Pharmaceuticals, Cipla, Dr Reddy’s Laboratories, Glenmark Pharmaceuticals, Wockhardt, Biocon, Biological E, Panacea Biotec, Torrent Pharma, Aurobindo Pharma, Intas Pharma, Natco Pharma and Lupine. The …

Read More »

Singapore Stock Exchange set to stop the bleeding on Thursday

[ad_1] (RTTNews) – Singapore’s stock market has fallen over consecutive trading days, losing nearly 10 points or 0.3% along the way. The Straits Times Index now sits just above the 3,225 point plateau, although it is expected to gain ground on Thursday. Global forecasts for Asian markets are stable to …

Read More »

Automatic factory for NC? Site recruiter says state is ready to be a player

[ad_1] RALEIGH – Whether North Carolina becomes home to a huge battery factory today or in the near future, the state is a candidate for future electric vehicle manufacturing. That’s what a well-known industrial site recruiter says. The state’s economic investment committee is due to meet today as discussions circulate …

Read More »

Yeh from PharmaEngine, first female winner at ITRI

[ad_1] Founder of PharmaEngine Inc (智 æ“Ž 生 技) Grace Yeh (葉常菁) became the first female Fellow of the Industrial Technology Research Institute (ITRI, 工業 技術 研究院) since it began awarding scholarships to business leaders 10 years ago. ITRI ​​President Lee Chih-kung (李世光) said at the 10th ITRI Laureates Awards …

Read More »

Strong Medication Needed To Get Protocol Through Before Christmas – Slugger O’Toole

[ad_1] The pace of Protocol negotiations is accelerating. Yesterday and earlier today, the BBC gave rare importance to this incomprehensible nationally (if you are not NI / Irish) topic. After today’s meeting the straws in the wind were a little more favorable but without Lord Frost clearly changing his position. …

Read More »

Gilead pays to retain rights to Arcus cancer drugs

[ad_1] Dive brief: Gilead will pay $ 725 million to retain the rights to four experimental cancer immunotherapies developed by Arcus Biosciences, Thursday announcement that it would confirm an option agreement the two companies signed in 2020. The most advanced projects involved are aimed at a cellular target called TIGIT …

Read More »

What does the J&J split mean for the medical device industry?

[ad_1] Wall Street analysts say Johnson & Johnson’s recent decision to split the consumer health unit into its own company is likely to spur growth and increase operating margins for the remaining segments of pharmaceuticals and medical devices. The health giant’s low-growth consumer health brands are a drag for pharmaceutical …

Read More »

Encouraging clinical trials in Wilson’s disease

[ad_1] Los Angeles, United States, October 26, 2021 (GLOBE NEWSWIRE) – Encouraging Wilson Disease Clinical Trials Strengthen Pipeline With Multiple Drugs In Pipeline, Says DelveInsight Several new therapies are under development for the treatment of Wilson’s disease. Among them, ALXN1840 and UX701 are at their most advanced stage (Phase III). …

Read More »